Integrating Structural Insights, Orthogonal Biophysics, and AI to Accelerate Discovery of Novel Targets and De-Risk Candidate Development Across Europe
The Rational Based Drug Design Summit Europe is Europe's dedicated meeting for structural biologists, biophysicists, medicinal chemists, computational chemists and AI drug discovery leaders advancing next-generation therapeutics.
As drug discovery teams face increasing pressure to identify better targets, reduce development risk and accelerate progression to the clinic, integrating structural biology, biophysics, medicinal chemistry and AI has become critical to making faster, more confident decisions.
Next January in Amsterdam, the inaugural Rational Based Drug Design Summit Europe will unite cross-functional drug discovery teams to share the latest strategies for identifying better targets, designing stronger candidates and accelerating progression to the clinic.
Who Will Attend?
The Rational Based Drug Design Summit Europe is designed for professionals working across the drug discovery ecosystem, including:
Structural Biology Leaders
Driving structure-enabled drug discovery with cryo-EM, crystallography & protein modelling.
Biophysics Experts
Advancing target validation, binding analysis & molecular characterisation.
Medicinal Chemists
Designing, optimising & progressing next-generation therapeutic candidates.
Computational Chemists
Applying modelling, simulation & in-silico approaches to drug discovery.
AI Drug Discovery Teams
Leveraging AI & machine learning to accelerate discovery decisions.
Discovery Scientists & Leaders
Guiding target identification, hit validation & candidate selection.
Attending Companies Include:
Partner with the Rational Based Drug Design Summit Europe
As innovation continues across structural biology, biophysics and AI-enabled drug discovery, the Rational Based Drug Design Summit Europe offers service and solution providers a focused platform to engage decision-makers and scientific leaders driving the future of pharmaceutical research.